Home
Technical
Publications
Macrophage NADPH oxidase inhibition by ultralow-dose dextromethorphan alleviates DSS-induced inflammation and colitis(KTE7007-8.2)

Macrophage NADPH oxidase inhibition by ultralow-dose dextromethorphan alleviates DSS-induced inflammation and colitis(KTE7007-8.2)

Date：2026-03-03 Views：48

Prev：Macrophage NADPH oxidase inhibition by ultralow-dose dextromethorphan alleviates DSS-induced inflammation and colitis(KTE7005-8.2)

Next：Macrophage NADPH oxidase inhibition by ultralow-dose dextromethorphan alleviates DSS-induced inflammation and colitis(KTE7009-8.2)

RECEIVE OFFERS BY EMAIL

CONTACT US

Welcome any form of communications, and better service will be provided here.

Tell： +1-404-854-0155

Email： service@abbkine.com

Support Email： support@abbkine.com

Address： 3052 Stroop Hill Road, Apt 203, Atlanta 30303, Georgia, United States of America

Links：

Copyright © 2012 - 2017 Abbkine, Inc. - All rights reserved